of cancer-associated mutations in p53 are missense mutations residing in its DNA-binding domain (DBD) Olivier et al., 2010) , leading to loss of tumor suppressive activity and possible gain of novel oncogenic functions (reviewed in (Oren and Rotter, 2010) ). In its wt form, p53 binds as a homo-tetramer to DNA response elements of its target genes, and orchestrates gene expression patterns to cope with cellular stress. In contrast, the effects of mutant p53 (mutp53) on target gene expression are more complex (Weisz et al., 2007) , and are thought to interfere with pivotal signaling pathways (Riley et al., 2008) . Previous studies in yeast have shown that different mutp53 variants exhibit altered transactivation capacity towards wtp53 target genes in a mutant-and target-dependent manner (Kato et al., 2003; Resnick and Inga, 2003) . This comprises a general reduction in transactivation capacity or an altered spectrum of regulated genes, including non-wtp53 target genes (Menendez et al., 2006; Resnick and Inga, 2003) . Interestingly, the residual transcriptional activity of a particular mutant is not directly indicative of the extent of its tumor suppressive functionality or its ability to induce apoptosis (Kakudo et al., 2005) .
Moreover, some p53 mutants ("super-trans mutants") exhibit increased transactivation potential towards particular targets, when compared to wtp53 (Resnick and Inga, 2003) . Thus, in order to determine the tumor-suppressive capacity of specific p53 mutations, the phenotypic impact of each mutation should be experimentally quantified. Such knowledge is of particular importance for the personalized treatment of cancer.
However, while the availability of patients' genomic sequences constantly increases, our understanding of mutation-specific biological effects remains a limiting factor. Specifically, detailed studies assessing the effects of p53 mutations in human cells has been largely limited to the most prevalent "hotspot" mutations, accounting for ~30% of cancer-associated mutations, leaving the remaining ~70% mostly uncharacterized. Deep mutational scanning (Fowler and Fields, 2014) offers a high-throughput approach for revealing the consequences of genetic variation both in regulatory and coding sequences (Brenan et al., 2016; Keren et al., 2016; Majithia et al., 2016; Tewhey et al., 2016; Ulirsch et al., 2016; Weingarten-Gabbay et al., 2016) . Yet, although the construction of a large-scale mutp53 library has recently been reported (Kitzman et al., 2015) , phenotypic characterization of such p53 mutants has not been performed.
To address this important knowledge gap, we designed a synthetic library of 9,833 unique ~200 nucleotide-long single-stranded DNA oligonucleotides encoding variations in the p53 DBD ( Fig.  S1 ). To delineate the impact of mutations derived from cancer samples and of asymptomatic natural polymorphisms, the library design included: (i) nearly all DBD mutations occurring in 28,869 tumor samples , most of which were previously unstudied; (ii) all possible permutations at each hotspot codon (378 variants), allowing their in-depth characterization; and (iii) combinations of naturally occurring SNPs (within the DBD) with additional DBD mutations, aimed to unravel possible genetic interactions (1,139 variants) . In addition, to systematically characterize the effect of mutations across the entire DBD, we created: all single-nucleotide substitutions, deletions and insertions (3,874 variants); all single amino acid substitutions requiring up to 2 nucleotide changes (3,480 variants) and dinucleotide transitions (e.g. CC>TT and GG>AA, 97 variants), as well as premature stop codons (304 variants) and inframe single and double (consecutive) amino acid deletions at each position (363 variants).
To achieve accurate mutagenesis of the entire DBD (residues 102-292, 573bp long), we generated 4 sub-libraries (labeled "A", "B", "C" and "D"), covering consecutive 141-144bp fragments of the DBD flanked by wtp53-homologues regions (Fig. 1a) . These sub-libraries were separately amplified and cloned into lentiviral vectors, yielding a mutp53 coding sequence followed by an internal ribosome entry site (IRES)-driven enhanced green fluorescent protein (EGFP) reporter; this bicistronic cassette allows estimation of relative mutp53 expression levels based on EGFP intensity. Library-encoding viruses were used to transduce p53-null H1299 (non-small cell lung cancer) cells at low multiplicity of infection (MOI=0.1), so that each transduced cell would express only a single mutp53 variant . Infected cultures were sampled at 2, 6, 9 and 14 days post-infection (PI), and the relative abundance of each variant at each time point was assessed using next-generation sequencing (Methods). Setting a minimum threshold of 200 reads per variant at the first time point (Fig. S2d ), we were able to capture the dynamics of 9,516 unique DNA sequence variants (97% of the designed variants), corresponding to 5,708 protein sequence variants. To piece together information on the entire DBD, data in each sub-library was normalized according to the dynamics of synonymous ("silent") mutation variants, compared across all sublibraries ( Fig. S2e and Methods).
To determine the relative changes in clonal abundance, we compared the fraction of reads corresponding to each sequence variant at 9 days PI to its fraction 2 days PI ( Fig. 1b) . Importantly, the relative abundance of all 571 synonymous sequence variants in the library, encoding wtp53, decreased within this time frame much faster than that of the 8,945 non-synonymous variants (mean depletion of ~6.55-fold versus ~1.45-fold for synonymous and non-synonymous, respectively; Mann-Whitney U p<10 -187 ). This is concordant with the well-documented antiproliferative effect of bona fide wtp53, as measured by flow cytometry and qRT-PCR in comparison to the entire library or to a p53-null control (Fig. S3a-c ). Furthermore, in contrast to all synonymous mutations, variants encoding the ten most prevalent p53 mutations across all tumor types were robustly retained in the population, demonstrating the ability of our system to recapitulate in vivo behavior and simultaneously map the phenotypic outcome of thousands of unique mutations (Figs. 1c, S3d, S4) . Similarly, variants encoding missense mutations in the 6 "hotspot" codons (averaged across all mutations in each codon) lacked a wtlike tumor suppressive effect and were well retained (ANOVA p<10 -10 ), albeit not showing a proliferative advantage over p53-null control cells. The latter might be because H1299 cells, naturally not "addicted" to mutp53, may require excessive mutp53 expression to elicit oncogenic gain-of-function, while a single integrated copy of our lentiviral vector only yields relatively low p53 levels in non-stressed cells.
To allow quantitative comparison between variants and improve measurement robustness, we took advantage of the repeated measurements at 6, 9 and 14 days PI, and calculated a relative fitness score (RFS) for each variant, based on its median retention (or depletion) across these three measurements (log 2 fold enrichment compared to first time point). Comparing the RFS calculated for different DNA sequence variants encoding the same amino acid substitution verified the robustness of our measurements (Fig. S5a, R=0.89, ). Unexpectedly, when averaging the effects of all DNA sequence variants encoding the same amino acid substitution, a bimodal distribution is observed (Figs. 1d) , where the great majority of p53 alterations can be discretely categorized as either retaining wtp53 functionality (strongly depleted in the population), or abrogating it (stably retained). A similar separation is evident when variants are displayed according to their DNA sequence (Figs. S5b, S6a, b) .
We next examined how amino acid sequence variations affect the RFS, as an indicator of wtp53like anti-proliferative capacity. To this end we calculated, for each assayed amino acid substitution at each position along the DBD, the median RFS measured for all DNA sequence variants encoding the same particular substitution ( Fig. 2a ). Notably, regardless of position along the DBD, premature termination codons and frameshift mutations resulted in a similarly strong disruption of p53 functionality ( Fig. 2a bottom rows in heatmap, Fig. S6c,d) . In contrast, the effects of substituting or deleting a single amino acid were strongly dependent on its position within the DBD. Thus, the L1 loop (residues F113-T123) and most of the L2 loop (residues K164-C176, C182-L194) are rather robust to alterations. Conversely, most mutations in the L3 loop (residues M237-P250) and the specific residues involved in coordination of zinc binding (R175, C176, H179, C238, and C242) compromise p53 functionality, in line with the documented importance of the zinc ion for the thermodynamic stability of the DBD (Bullock et al., 1997; Duan and Nilsson, 2006) . Furthermore, hierarchical clustering of the relative fitness scores across the DBD (Figs. 2b, S7a,b) grouped amino acids with similar biochemical properties close to one another. Thus, valine co-clustered with isoleucine and leucine, while aspartate co-clustered with glutamate, and phenylalanine co-clustered with tryptophan and tyrosine. Hence the effects of mutations on relative fitness capture the sequence-structure-function relationships in p53. Notably, as observed for specific variants (Fig. 1d ), the majority of codons segregated into two major groups displaying opposing phenotypic responses to mutagenesis ( Fig. S7b ).
We then calculated an evolutionary conservation score (ECS, Methods) for each residue along the DBD from a multiple sequence alignment of 1887 homologous sequences, which correspond to 246 non-redundant sequences when clustering sequences that are more than 80% identical.
Comparing ECS values with codon mean RFS measurements revealed a strong correlation ( Fig.   2a ,c, R s =0.79, p<2x10 -41 ), highlighting the tight coupling between p53 protein sequence evolutionary conservation and vulnerability to functional alteration. We further utilized this conservation-functionality connection to blindly predict the effects of amino acid substitutions on protein functionality using a statistical model of sequence variation in the alignment, based on evolutionary bias towards or away from specific residues at each position ( Fig. 2d, Methods ). This unsupervised model, which accounts for site-specific amino acid constraints alone and does not explicitly model a specific phenotypic functionality, showed a significant correlation to our experimental measurements (R s =-0.59, p<2x10 -283 ), suggesting that RFS reflects a p53 functionality which is under evolutionary selection. Despite this correlation, some variants that were predicted to retain at least partial wtp53 functionality exhibited complete loss of antiproliferative activity. This discrepancy may suggest the existence of additional context-dependent functionalities that are not evident in H1299 cells, in line with p53's involvement in multiple nonredundant processes (Kakudo et al., 2005; Pfister and Prives, 2017) .
Closer examination of the mutational effects within specific codons revealed 3 distinct response patterns of codons to mutations: (i) positions highly susceptible to mutation (i.e. substitution to nearly any amino acid abolished anti-proliferative p53 functionality), including the hotspot codons G245, R248, R249 and R273 (Fig. 3a) ; (ii) positions resilient to mutations, tolerating practically all substitutions (with the frequent exception of proline) without losing p53 functionality (Fig. 3b) ; and (iii) codons in which a continuous phenotypic spectrum is observed, with mutation outcome largely depending on the specific substitution ( Fig. 3c ). Interestingly, the latter group includes the hotspot residues R175 and R282, extending earlier observations (Ory et al., 1994) . Altogether, our findings demonstrate the merit of in-depth functional characterization of p53 mutations, even at hotspot positions.
Overlaying the relative evolutionary representation (i.e. the percent of species in which that particular amino acid is present at a given position) over the measured phenotypic effect for each of the substitutions, reveals that the mean relative representation of variants retaining wtp53 functionality is dramatically higher than in non-functional variants ( Fig. 3a-d ; Student's T p<10 -38 ). Thus, the functional impact of mutations in human cells faithfully reproduces the constraints that shape the DBD sequence during evolution. Notably, the differences in robustness of codons to modification are concordant with known p53 structure-function dependencies: superimposing the mean RFS of each codon on the protein's 3D structure shows that residues positioned in proximity to the DNA are generally more functionally vulnerable ( Fig. 3e ). Together, these strong associations between our functional measurements, conservation and structure, position canonical anti-proliferative p53 capacity as a pivotal property under strong evolutionary selection.
Assessing the contribution of specific mutations to cancer features is key to patient-specific tailoring of treatment. We therefore asked whether the relative fitness effects measured in vitro correspond with the prevalence of particular p53 mutations in human tumors. Reassuringly, this analysis ( Fig. 4a ) revealed that p53 mutation prevalence across all tumor types is positively correlated with RFS (R s =0.4, p<4x10 -57 ). Intriguingly, in apparent discordance with the overall picture, we also observed mutations that are rare in tumors despite having lost p53 functionality (dashed triangle, Fig. 4a ). Thus, the importance of such variants could not be deduced from mutation prevalence, emphasizing the necessity of direct functional measurement. Closer examination of these mutations revealed a marked enrichment in variants requiring more than a single nucleotide change, or a purine-pyrimidine transversion. When excluding such variants from the analysis and retaining only protein sequence alterations achievable by a single A-G or C-T transition, the correlation between mutation prevalence and loss of functionality increases ( Fig.   4b , R s =0.52, p<2x10 -38 ). Fitting a logistic function to the data managed to explain a large fraction of the variability (R 2 =0.49) in relative fitness of transition mutants on the basis of clinical prevalence. The sigmoid relationship, and the apparent separation of the ~10 most prevalent mutations without a further increase in relative fitness, suggest that additional explanations underlie the high prevalence of those hotspot mutations. These may include oncogenic effects not captured by our assay, or a mechanistic tendency towards accrual of mutations at those sites.
To further elucidate the forces shaping the spectrum of cancer-associated p53 mutations, we trained a "Random Forest" learning algorithm to predict mutation prevalence in human tumors.
We applied 200-fold cross-validation (CV) using 90% of our data to predict mutation abundance according to mutation type and outcome, position, the probability of occurrence of similar substitutions (genome-wide, along evolution), residue evolutionary conservation and the measurements obtained in our phenotypic assay. This model predicted relative mutation abundance with an R=0.72 (p<10 -100 ) and R=0.75 (p<3x10 -27 ) on CV and 10% unseen test cases, respectively (Figs. 4c, S8a). Importantly, the most contributing feature in this prediction task was our measured RFS score ( Fig. S8c ), demonstrating the importance of direct systematic assessment of pan-mutation effects, and underscoring the connection between loss of anti-proliferative capacity and prevalence in cancer.
Next, we attempted the complementary task of predicting variants' RFS using the above mutation features, substituting all experimental measurements with mutation prevalence (Figs. 4d, S8b, d) .
Once again, our trained model enabled accurate prediction of mutational outcome (R=0.87, p<10 -100 and R=0.88, p<2x10 -47 in CV and on unseen test cases, respectively), providing a reliable estimation of the phenotypic effects of p53 variants of unknown significance (VUS). Such knowledge is very valuable, for example in assessing the possible implications of a particular TP53 germline mutation identified by pre-or postnatal genetic testing.
TP53 germline mutations underpin the majority of cases of Li-Fraumeni syndrome (LFS), an inherited cancer predisposition resulting in early-onset tumors including sarcomas, breast cancers and adrenocortical tumors (Li et al., 1988; Malkin et al., 1990) . Importantly, tumors are observed at an earlier age in LFS family members harboring p53 DBD mutations that compromise anti-proliferative functionality (RFS>-1), when compared to those bearing TP53 germline mutations that retain anti-proliferative capacity (RFS≤-1), highlighting the prognostic value of the RFS score ( Fig. 4e , Mann-Whitney U p<10 -9 across all cancers). Of note, the age at tumor diagnosis (ATD) is similar in LFS family members with truncating TP53 mutations (frameshift or nonsense) and in members with functionally-disruptive missense mutations, as predicted by our functional in vitro measurements ( Fig. S9 ). Yet, individuals with the 6 most prevalent hotspot mutations exhibit an even somewhat lower ATD (Kruskal-Wallis p<0.01), suggesting that they elicit additional gainof-function effects not captured by our experimental system. Finally, we took advantage of our assay to evaluate the significance of SNPs within the p53 DBD.
Although highly conserved, the DBD nevertheless harbors several polymorphic variations. For example, V217M (rs35163653, resulting from a G>A transition), a non-synonymous validated SNP (Whibley et al., 2009) , has been functionally studied in yeast, where it induced elevated expression of CDKN1A, BAX and NOXA (Kato et al., 2003) and in human cells, where its transcriptional signature was indistinguishable from that of wtp53 (Wang et al., 2014) . Another rare polymorphism within the DBD is R213R (rs1800372), caused by a synonymous A>G transition in exon 6. So far, these SNPs have not been associated with cancer risk (Ganci et al., 2011; Pilger et al., 2007; Sharma et al., 2014) . Nevertheless, in the presence of secondary acquired mutations, these SNPs may affect cancer predisposition or aggressiveness. In search for combinatorial effects, we combined these SNPs with all single-base mutations residing in sublibrary C. Interestingly, while on both backgrounds nonsense and frameshift mutations yielded a similar complete loss of p53 functionality, the effects of missense mutations were found to largely depend on genetic background (Figs. 5a,b, S10): while the R213R background slightly enhanced p53 functionality, the V217M background rendered the acquisition of "mild" missense mutations more disruptive to p53 function (higher RFS on SNP background relative to wt background). These results exemplify the importance of background (asymptomatic) coding sequence polymorphisms in shaping the outcome of cancer gene mutations, underscoring the merit of personalized genetic analyses.
Our findings provide a first comprehensive catalogue for the functional consequences of thousands of p53 DBD mutations in human cells, and potentially hold important clinical implications. Our cell-based measurements are highly indicative of the in vivo functional outcome of p53 mutations.
Thus, tumor-associated p53 mutations retaining wtp53-like anti-proliferative functionality are rather unlikely to be driver mutations. In addition, our observations highlight the importance of direct measurement of mutation impact to determine the outcome of VUS, and justify large-scale systematic scans aimed to broaden our understanding of mutation-driven phenotypic landscapes.
Conceivably, p53 mutations that retain wtp53-like functionality in this assay may nevertheless still endow cancer-supportive phenotypes in a context-dependent manner. Yet, the high concordance of our functional measurements with human mutation prevalence, structural motifs and evolutionary conservation, argues that biochemical features underpinning the anti-proliferative effects of p53 in this model are also seminal for its tumor suppressor activity, as well as for its primordial biological functions. Future studies should further expand our understanding of context-dependent mutational effects.
Methods:
Cell culture. Human embryonic kidney cells 293T (HEK 293T) were cultured in Dulbecco's modified Eagle's medium (Biological Industries, Beit-Haemek, Israel (BI)) supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS, BI) and 1% penicillin and streptomycin (P.S., BI). H1299 human lung carcinoma cells were cultured in RPMI1640 medium (BI), supplemented with 10% HI-FBS and 1% P.S. All cells were kept at 37°C in a humidified atmosphere containing 5% CO 2 and were frozen in freezing medium (90% HI-FBS + 10% dimethyl sulfoxide (DMSO, Sigma). Trypsin-EDTA solution C (BI) was used to detach cells from culture dishes.
Plasmids. The pPRIG plasmid (pPRIG-Hd-HA-Red (Martin et al., 2006) ) was kindly provided by the Pognonec lab (Université de Nice Sophia Antipolis, Nice, France). pEF1_EMCV_ Western blot. Immunoblot analysis was performed as previously described (Hoffman et al., 2014) . Antibodies used were: p53 (mixture of DO1 + PAb1801); vinculin (Sigma).
Synthetic library production and amplification. Initial library synthesis and amplification were based on a protocol previously used for yeast promoter libraries (Sharon et al., 2012) . Pools of fully-designed ~200-residue long single-stranded DNA oligonucleotides were obtained from Agilent Technologies (Santa Clara, CA). To achieve accurate mutagenesis of the entire DBD (573bp long, total of 9,833 sequence variants), the complete library is composed of 4 sub-libraries, each covering a different 141-144bp fragment of the DBD ("DBD-A" covers residues 102-149, "DBD-B": . Each modified segment contains common wtp53-homologous sequences (at least 20 nucleotides long) at both ends, to enable initial PCR amplification and restriction-free (RF) cloning into the vector (described below). To avoid non-specific concatamerization due to overlapping sequences, these 4 sublibraries were obtained in two separate pools, each covering sequence variations in non- For cloning of the p53 libraries into lentiviral vectors, we first cloned a pEF1a-wtp53-EMCV-EGFP master plasmid by substituting the mRFP sequence of pEF1_EMCV_ (Kazadi et al., 2008) with a wtp53 sequence using restriction-free (RF) cloning (Unger et al., 2010) . Thus, the wtp53 coding sequence was amplified by PCR from pC53-SN3 (Baker et al., 1990) digestion was performed using the same enzymes, in a reaction-mixture containing: 18µl Fast Digest buffer, 15µg of the plasmid library, 9µl of each enzymes and DDW up to a total volume of 180µl. The mixture was divided into three tubes and incubated for 2.5 hours at 37°C, followed by 20 min inactivation at 65°C. Then, alkaline phosphatase (FastAP, Thermo Fisher Scientific) was added to each tube (3µl of Fast AP buffer, 3µl of FastAP enzyme and DDW up to a total volume of 30µl). The mixture was incubated for an additional 30 min at 37°C, followed by 20 min inactivation at 65°C.
Restriction-digested libraries and plasmid were separated by electrophoresis on a 1.5% agarose gel stained with ethidium bromide. Fragments of the correct size were excised from the gel and samples were purified first using Qiagen Gel extraction kit (cat #28704) and then with a Gel and PCR clean-up purification kit (NucleoSpin, cat #740609). Next, library-vector ligations were performed using 1µl of Lucigen ligase, 10xLucigen buffer, molar ratio of 1:1 (vector: library) and DDW to a final volume of 10µl. Ligation products were transformed into E.cloni (Lucigen) with 2µl of ligation mix, as described in Step 1, collecting a total of 2.75x10 5 , 1.53x10 5 , 3.57x10 5 and 3.94x10 5 colonies from libraries A, B, C and D, respectively. Colony PCRs were performed for validation as described above, and plasmids were extracted using NecleoBond Xtra Maxi kit (cat #740414.10).
Lentivirus production and infections. For lentiviral packaging, 2.1x10 6 HEK293T cells were seeded on 10cm plates pre-coated with poly-L-lysine 0.001% (Sigma), incubated for 20 min, and washed three times with phosphate-buffered saline (PBS). 16hr later, cells were co-transfected with three helper plasmids (5.2µg pMDL, 3.2µg pVSVG and 2µg pRSV-Rev) and 8µg of libraryencoding plasmid. Transfections were performed using jetPEI DNA transfection reagents (Polyplus Transfection) according to the manufacturer`s instructions and medium was replaced after 6-8hr. Virus containing medium was collected at 48 and 72hr post-transfection, filtered with 0.45-µm filters (Mercury), aliquoted and stored at -80C.
To determine viral titer, 6x10 5 H1299 cells were plated in 10cm dishes 16 hours prior to infection.
A single aliquot from each viral library was thawed at 37 0 C, and serially diluted in RPMI1640. respectively. gDNA was purified using DNeasy blood and tissue kit (Qiagen). For each measurement, a two-step nested PCR was performed: First, the entire DBD region was amplified (performed identically for all 4 sub-libraries). Then, in each experiment the relevant sub-library DBD fragment was amplified using primers specific to the modified region in that sub-library. In the first step (performed in multiple tubes to include the required amount of gDNA), each reaction contained a total volume of 100µl with 10µg gDNA, 50µl of Kapa Hifi ready mix X2 (KAPA Biosystems) and 5µl of each (10mM) primer. The parameters for PCR were 95 0 C for 5min, 18 cycles of 94°C for 30s, 65°C for 30s, and 72°C for 30s, followed by one cycle of 72°C for 5 min. Paired-end reads were merged using Usearch (http://www.drive5.com/usearch/) setting a minimal overlap of 80 and merge length of 180-220. Merged reads in each sample were mapped to the library design, requiring a perfect sequence match, and the number of reads corresponding to each sequence variant were counted. We required a minimal coverage of >200 reads for each sequence variant at the first experimental time point. This stringent threshold, together with the large number of cells infected with each library variant as described above, enabled to average out the effects of random lentivirus integration and reduce measurement noise. ~97% of the designed sequence variants (9,516 of 9,833) passed this threshold and were further used in the analysis.
As each of the 4 sub-libraries was measured separately, data in each sub-library was normalized according to the dynamics of synonymous mutation variants, compared across all sub-libraries.
Thus, for each sequence variant, we calculated the log (base 2) fold-change (FC) at each time point and normalized the log-FC of all variants in each sub-library so that the mean log-FC across synonymous variants (encoding a wtp53 amino acid sequence) in that sub-library will equal the mean log-FC of all synonymous variants (across all libraries).
The relative fitness (RFS) score for each variant was calculated as:
Where , 1 is the relative enrichment/depletion of the variant at time point 3 :
, 1 = log 7 , 1 , 9
, 3 represents the fraction of reads corresponding to a variant at the given time point ( : , 7 and ; , represent sampling at 6, 9 and 14 days post-infection, respectively.
The evolutionary conservation score (ECS) measures how conserved each position is in a multiple sequence alignment of the protein family (Sander and Schneider, 1991) . It is defined as the normalized entropy of the distribution of amino acid frequencies f i in position i, i.e.
lnq and sums over all amino acid characters a in the alignment including the gap, and q=21. ECS(i) ranges from 0 (completely variable) to 1 (fully conserved). Amino acid frequencies were obtained from a sequence alignment of 1887 homologous sequences obtained by a jackhmmer search against the UniRef100 sequence database (5 iterations, E-value threshold: 1E-01). To reduce sequence redundancy when calculating the frequencies, the counts for each sequence were weighted by 1/m, where m is the number of sequences in the alignment that are at least 80% identical (redundancy-reduced number of sequences: 246) (Hopf et al., 2017) .
Relative evolutionary representation of amino acid residues was calculated using the ConSurf (Ashkenazy et al., 2016) tool using default parameters (homologous sequences taken from UniRef90 database, and filtered for sequence homology ranging between 35-95%). Relative representation is defined as the percent out of the 150 examined species in which that particular amino acid is present at a given position.
To predict the effects of individual amino acid substitutions from evolutionary sequences, a statistical model of the family sequence alignment was inferred (Hopf et al., 2017) . Since there is only limited evolutionary sequence diversity in the family alignment (redundancy-reduced number of sequences: 246), we chose to infer a simple site-independent model rather than an epistatic model that considers amino acid dependencies between pairs of positions, as described previously (Hopf et al., 2017) . This choice is supported by the observation that only 29 significant long-range evolutionary couplings between pairs of positions could be detected at a 90% probability cutoff when inferring an epistatic model (Toth-Petroczy et al., 2016) .
Briefly, the independent model describes the probability of any amino acid sequence σ in the family by = 1 ℎ 3 3 3 with single-site amino acid constraints h i (σ i ) capturing the preference for amino acid σ i in position i. These parameters are inferred from the sequence alignment using l 2 -penalized maximum likelihood inference. The effect of a substitution ΔE can then quantified by the log-odds ratio of the probabilities of the mutant and wild-type sequences under the model:
A score of 0 putatively corresponds to neutral substitutions, scores < 0 to deleterious substitutions, and scores > 0 to beneficial substitutions.
The structural model of p53 was created with PyMol using the 1TSR p53 structure downloaded from the Protein Data Bank (http://www.rcsb.org/pdb/).
Mutation prevalence and RFS prediction models. All predictions were performed with Random
Forest regression models, using the scikit-learn (Pedregosa et al., 2011) RandomForestRegressor class. In each of the prediction tasks, we randomly partitioned the data into a 90% training set and a 10% test set which was left aside and not used for model fitting and optimization. To tune model parameters and assess its performance on training data we used a 200-fold cross validation scheme.
Model parameters were adjusted to maximize the Pearson correlation between predicted and measured values. These parameters were then used for fitting the model using the entire training data set and final prediction on unseen test data.
Model features include: mutation prevalence , measured RFS; variant enrichment at 6, 9 and 14 days (log-FC of read fractions over the 2d time point) and relative abundance at 2 days; mean enrichment at 6, 9 and 14 days; position within the DBD; residue evolutionary conservation and residue percent variability; "independent model" prediction of protein functionality; 'epistatic model' prediction of protein functionality calculated using EVmutation (Hopf et al., 2017) ; minimal number of transitions and transversions required to achieve the given amino acid alteration; type of mutations (substitution, deletion, insertion or tandem base transitions) and their outcome (missense, nonsense, silent); and PAM250 and BLOSUM62 substitution matrix values. Feature importance was assessed by mean decrease in impurity, as implemented in scikit-learn (Pedregosa et al., 2011) .
Statistical analyses. To assess the difference between two groups of values that are distributed approximately normal, we used Student's t test. When this was not the case we performed nonparametric tests: Mann-Whitney U test for independent samples (e.g. in Fig. 1b ), or Wilcoxon signed-rank test for matched samples (e.g. Figs. 4e and f) . All performed statistical tests were twosided. To assess the difference between time-course dynamics (e.g. in Fig. 1c) we performed a within-subjects two-way analysis of variance (ANOVA). For comparison between ages of tumor onset in patients harboring different mutation types we performed a one-way Kruskal-Wallis H test (Fig. S9 ). All error bars represent ±SEM (standard error of the mean), unless noted otherwise.
Heatmap hierarchical clustering was performed using a Euclidean distance matrix. Statistical analyses were performed using the scipy python package. Figure 1 corresponding to rows and columns in Fig. 2b, respectively. 
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